According to GlobalData’s medical device pipeline database, 83 Diabetes Assays devices are in various stages of development globally. GlobalData’s report Diabetes Assays provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 40 are in active development, while the remaining 43 are in an inactive stage of development. There are 23 products in the early stages of development, and the remaining 17 are in the late stages of development.
This segment comprises of C-Peptide Assay, Glycated Hemoglobin (HbA1c) Lab Assay, Glycated Hemoglobin (HbA1c) Point of care (POC) Assay, Insulin Assay and Fasting Glucose Assay
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Diabetes Assays pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Diabetes Assays devices. Overall, most of these Diabetes Assays pipeline devices are being developed by private entities.
Key players involved in the active development of Diabetes Assays include Beckman Coulter, Guangzhou Wondfo Biotech, Aura Biotechnologies, Enable Biosciences, University of Florida, CellCarta Precision Medicine, Abionic, Advanced Genetic Diagnostics, Human Cell Design and Interpace Biosciences.
For a complete picture of the developmental pipeline for Diabetes Assays devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.